title: Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral.
authors.affiliation: Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Québec, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Cantarovich
authors.forename: J
authors.initials: J
authors.lastname: Barkun
authors.forename: J G
authors.initials: JG
authors.lastname: Besner
authors.forename: P
authors.initials: P
authors.lastname: Metrakos
authors.forename: E
authors.initials: E
authors.lastname: Alpert
authors.forename: M
authors.initials: M
authors.lastname: Deschénes
authors.forename: Z
authors.initials: Z
authors.lastname: Aalamian
authors.forename: J I
authors.initials: JI
authors.lastname: Tchervenkov
mesh_terms: D000284:Administration, Oral; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine